Area under the concentration–time curve to minimum inhibitory concentration ratio as a predictor of vancomycin treatment outcome in methicillin-resistant Staphylococcus aureus bacteraemia-Reference-Cited by-同舟云学术

Area under the concentration–time curve to minimum inhibitory concentration ratio as a predictor of vancomycin treatment outcome in methicillin-resistant Staphylococcus aureus bacteraemia

Published:2014-02 Issue:2 Volume:43 Page:179-183
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Jung Younghee,Song Kyoung-Ho,Cho Jeong eun,Kim Hyung-sook,Kim Nak-Hyun,Kim Taek Soo,Choe Pyoeng Gyun,Chung Jae-Yong,Park Wan Beom,Bang Ji Hwan,Kim Eu Suk,Park Kyoung Un,Park Sang-Won,Kim Hong Bin,Kim Nam Joong,Oh Myoung-don

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference15 articles.

1. The concentration-independent effect of monoexponential and biexponential decay in vancomycin concentrations on the killing of Staphylococcus aureus under aerobic and anaerobic conditions;Larsson;J Antimicrob Chemother,1996

2. Analysis of vancomycin time-kill studies with Staphylococcus species by using a curve stripping program to describe the relationship between concentration and pharmacodynamic response;Ackerman;Antimicrob Agents Chemother,1992

3. Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections;Moise-Broder;Clin Pharmacokinet,2004

4. Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targets;Kullar;Clin Infect Dis,2011

5. Vancomycin AUC24/MIC ratio in patients with complicated bacteremia and infective endocarditis due to methicillin-resistant Staphylococcus aureus and its association with attributable mortality during hospitalization;Brown;Antimicrob Agents Chemother,2012

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential risk factors for early acute kidney injury in patients treated with vancomycin;Journal of Infection and Chemotherapy;2024-10

2. Is It Still Beneficial to Monitor the Trough Concentration of Vancomycin? A Quantitative Meta-Analysis of Nephrotoxicity and Efficacy;Antibiotics;2024-05-28

3. Contemporary pharmacologic treatments of MRSA for hospitalized adults: rationale for vancomycin versus non-vancomycin therapies as first line agents;Expert Review of Anti-infective Therapy;2023-11-02

4. The Influence of a Therapeutic Drug Monitoring Service on Vancomycin‐Associated Nephrotoxicity;The Journal of Clinical Pharmacology;2023-10-25

5. Recommended doses of endovenous vancomycin are insufficient to achieve therapeutic concentrations in paediatric patients;European Journal of Hospital Pharmacy;2023-04-27